Shawn Fatholahi

Shawn Fatholahi is the current President & CEO at Maxona Pharmaceuticals. Shawn has over 25 years of experience in the pharmaceutical industry, including previous positions as Vice President of Sales and Marketing at Impax Laboratories, Vice President of the Healthcare Practice at First Rennaisance Ventures, and Marketing at Cephalon and ASTA Medica GmbH. Shawn started their career in 1989 at SmithKline Beecham, where they worked in sales and marketing for 7 years before moving on to Bristol-Myers Squibb.

Shawn Fatholahi has a BS in Biology from The University of Akron and an MBA in Systems Management & Leadership from Baldwin Wallace University.

Some individuals on their team include Bob Rappaport - Chief Regulatory Advisor, Arthur Koch, Jr. - Chief Financial Officer, and Edward Allera - GC & Chief Legal Advisor.